Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Radiotherapy with BRAF inhibitor therapy for melanoma: progress and possibilities.

Future oncology (London, England) - 1 Jan 2016

Zahnreich Sebastian, Mayer Arnulf, Loquai Carmen, Grabbe Stephan, Schmidberger Heinz

Abstract excerpt

The introduction of small molecule BRAF(V600) kinase inhibitors represents a milestone in the targeted therapy of patients with metastatic melanoma by a significant increase in therapeutic efficacy in terms of overall and progression-free survival compared with conventional chemotherapy. Beside BRAF(V600) inhibitor treatment, radiotherapy is a further mainstay for the therapy of metastatic melanoma and thus a...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Combined Modality Therapy
Share to BRAF gene
Share to Melanoma

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Mutation

Share to Protein Kinase Inhibitors

Share to Proto-Oncogene Proteins B-raf

Share to Radiation Tolerance

Source

Identifiers

PMID: 26616061
DOI: 10.2217/fon.15.297

Genes

BRAF

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Radiotherapy with BRAF inhibitor therapy for melanoma: progress and possibilities.PMID 26616061Read ↗

Sequence-dependent cross-resistance of combined radiotherapy plus BRAFV600E inhibition in melanomaSemantic proximity Read ↗

BRAF-MEK inhibition in melanoma brain metastases: a new hope.Semantic proximity Read ↗

BRAF Inhibitors and Radiation Do Not Act Synergistically to Inhibit WT and V600E BRAF Human Melanoma.Semantic proximity Read ↗

The potential of BRAF-targeted therapy combined with immunotherapy in melanoma.Semantic proximity Read ↗

Radiation necrosis mimicking rapid intracranial progression of melanoma metastasis in two patients treated with vemurafenib.Semantic proximity Read ↗

BRAF Mutation Correlates with Worse Local-regional Control Following Radiation Therapy in Patients with Stage III MelanomaSemantic proximity Read ↗

BRAF mutation correlates with worse local-regional control following radiation therapy in patients with stage III melanoma.Semantic proximity Read ↗

Radiotherapy utilization in BRAF mutation-tested metastatic melanoma in the targeted therapy era.Semantic proximity Read ↗

Principles of Targeted Therapy for Melanoma.Semantic proximity Read ↗

Impact on overall survival of the combination of BRAF inhibitors and stereotactic radiosurgery in patients with melanoma brain metastases.Semantic proximity Read ↗

miR-185 enhances the inhibition of proliferation and migration induced by ionizing radiation in melanomaSemantic proximity Read ↗

Integrating BRAF/MEK inhibitors into combination therapy for melanomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.